FDA Approves PHENYLEPHRINE HYDROCHLORIDE — Baxter Healthcare Corporation

# FDA Approves Baxter Healthcare's Generic Phenylephrine Hydrochloride Injection Baxter Healthcare Corporation has received FDA approval for its generic phenylephrine hydrochloride intravenous formulation (ANDA217032), expanding the competitive landscape for this critical vasopressor medication used in acute care settings. The approval is expected to increase price competition and improve market access for this essential injectable pharmaceutical in the hospital and emergency care segments.